229 related articles for article (PubMed ID: 2447021)
1. Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas.
Ohuchi N; Simpson JF; Colcher D; Schlom J
Int J Cancer; 1987 Dec; 40(6):726-33. PubMed ID: 2447021
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of carcinoembryonic antigen in early gastric adenocarcinomas versus benign gastric lesions defined by monoclonal antibodies reactive with restricted antigen epitopes.
Ohuchi N; Wunderlich D; Fujita J; Colcher D; Muraro R; Nose M; Schlom J
Cancer Res; 1987 Jul; 47(13):3565-71. PubMed ID: 3555774
[TBL] [Abstract][Full Text] [Related]
3. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
5. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
6. Complementation of expression of carcinoembryonic antigen and tumor associated glycoprotein-72 (TAG-72) in human colon adenocarcinomas.
Simpson JF; Primus FJ; Schlom J
Int J Biol Markers; 1991; 6(2):83-90. PubMed ID: 1716293
[TBL] [Abstract][Full Text] [Related]
7. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated glycoprotein (TAG-72) detected in adenocarcinomas and benign lesions of the stomach.
Ohuchi N; Thor A; Nose M; Fujita J; Kyogoku M; Schlom J
Int J Cancer; 1986 Nov; 38(5):643-50. PubMed ID: 2429933
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
[TBL] [Abstract][Full Text] [Related]
11. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
[TBL] [Abstract][Full Text] [Related]
12. Applications of immunocytochemistry to clinical cytology.
Johnston WW; Szpak CA; Thor A; Simpson JF; Schlom J
Cancer Invest; 1987; 5(6):593-611. PubMed ID: 3327572
[TBL] [Abstract][Full Text] [Related]
13. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
Irvine K; Schlom J
Cancer Immunol Immunother; 1993 May; 36(5):281-92. PubMed ID: 7682893
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of B72.3 with adenocarcinomas. An immunohistochemical study of 476 cases.
Loy TS; Nashelsky MB
Cancer; 1993 Oct; 72(8):2495-8. PubMed ID: 8402466
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
Johnston WW; Szpak CA; Thor A; Schlom J
Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
[TBL] [Abstract][Full Text] [Related]
16. Production of monoclonal antibodies to serum antigens in colorectal carcinoma.
Teh JG; Thompson CH; McKenzie IF
J Immunol Methods; 1988 May; 110(1):101-9. PubMed ID: 3286775
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of canine carcinomas with monoclonal antibody B72.3.
Clemo FA; DeNicola DB; Delaney LJ
Vet Pathol; 1993 Mar; 30(2):140-5. PubMed ID: 8470336
[TBL] [Abstract][Full Text] [Related]
18. Serologic mapping and biochemical characterization of the carcinoembryonic antigen epitopes using fourteen distinct monoclonal antibodies.
Kuroki M; Greiner JW; Simpson JF; Primus FJ; Guadagni F; Schlom J
Int J Cancer; 1989 Aug; 44(2):208-18. PubMed ID: 2474516
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4.
Pancino G; Osinaga E; Charpin C; Mistro D; Barque JP; Roseto A
Br J Cancer; 1991 Mar; 63(3):390-8. PubMed ID: 1706194
[TBL] [Abstract][Full Text] [Related]
20. Reactivities of an anti-CEA peptide monoclonal antibody.
Horan Hand P; Simpson JF; Kuroki M; Parker R; Schlom J
Int J Biol Markers; 1992; 7(1):1-15. PubMed ID: 1374782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
